1. Market Research
  2. > Healthcare Market Trends
Preterm Labor Treatment Market

Preterm Labor Treatment Market

  • July 2019
  • 132 pages
  • ID: 6019149
  • Format: PDF
  • Straits Research


Table of Contents

The global preterm labor treatment market was valued at USD 795.75 million in 2019 and is expected to grow at a CAGR of 5.1% during the forecast period, 2020–2029.

Prevalence of premature birth is growing worldwide due to lack of adequate health care and less exposure to antennatal health check-up during pregnancy. With rising hectic lives and lifestyle-related pressures, women are becoming more likely to consider a number of ways to alleviate or relive stress. In several research, it has been shown that the preterm labour rate is high among heavy and moderate smokers relative to average individuals. For instance, according to the American Pregnancy Association, more than 1000 neonatal dies each year due to smoking in the U.S. and the number is likely to surge in the coming years. Besides, Rising incidences of chronic diseases such as high blood pressure and diabetes among younger women across the globe are leading to an increasing market for pre-term labour care. According to the International Diabetics Federation, in 2019, a 20 million or 16% of live births had some form of hyperglycaemia in pregnancy and an estimated 84% were due to gestational diabetes. However, lack of awareness about preterm labor diagnosis in developing regions is hampering the market growth significantly.

Tocolytic drugs segment dominated the market by drug, accounting for the largest revenue share of around 43% in 2019

Based on drug, the global preterm labor treatment market can be segmented into natural type colloids and synthetic type colloids.

Tocolytic medications are used to slow down uterine contractions and postpone delivery for a limited period to buy more time for corticosteroids and magnesium sulphate therapy. Extended time also allows the patient to explore alternative care choices, and is one of the primary reasons boosting demand for tocolytic medications. Physicians administer these medications to combat maternal instability, preeclampsia, placental abruption, gene defects, and intrauterine infection. For example, as per the American Alliance, Preterm Premature Membrane Breakdown (pPROM) is responsible for 30-40% of preterm births and affects 150,000 women a year in the United States. AstraZeneca, Lannett Lamaze International, Stragen Pharma SA, Zuventus HealthCare Ltd and Dexa Medica are some of the leading tocolytic drug manufacturers.

Injections amongst dosage form segment dominated the market in terms of revenue in 2019 and is expected to grow at highest CAGR of 5.5% in the forecast

Based on dosage form, the global preterm labor treatment market is be segmented into tablets and capsules, injection, and others.

Injections are used for the prompt release of medications under critical circumstances during preterm labour therapy for accelerated onset of action. Thus, whether the patient is unconscious or in any kind of emergency, the injection dose method is the preferred option for the administration of medications in pre-term labour care. Corticosteroids, such as dexamethasone, are available in the market for immediate action in the injection delivery form. Parenteral therapy is necessary for pre-term labour treatment for some medicines that are not effective through oral route of administration in the form of tablets and capsules and require injection; for example, magnesium sulphate, taken orally, might induce bowel movement within 30 minutes.

Hospitals to lead end user segment

Based on end user, the global preterm labor treatment market is be segmented into hospitals, nursing homes, and others.

The hospital sector has a large market share due to the massive availability and penetration of government and private hospitals across the globe. A variety of specialised facilities are now offered in hospitals with centralised diagnostic centres. According to the American Hospital Association, the overall number of hospital beds in the United States rose by 8.4% in 2017 relative to 2015. This is further reinforced by the development of the health care infrastructure of developing countries, including North America and Europe, which plays a major part in the overall reimbursement of medical costs. For instance, the European Health Insurance Card (EHIC) or the Provisional Replacement Certificate (PRC) covers medical costs and takes the appropriate steps to reduce costs in the event of high-risk pregnancy. Gynecologists have been observed to administer more intravenous and intramuscular immediate effects drugs. In line with the growing cost of hospital life for premature babies, the industry is expected to see substantial growth in the coming years.

America is the largest geographical market in terms of revenue and is anticipated to grow at a CAGR of 4.5% during the forecast period

North America has a large share of the worldwide pre-term labour market. This can be due to a moderate incidence of premature birth, a high level of health care spending, a high level of understanding among parents, a significant number of women who smoke, and a high level of approval of IVF. With the rapid adoption of progressive technologies such as IVF in the region, the prevalence of premature birth has also amplified coupled with numerous complications during pregnancy. To cover these complications, physician are prescribing a range of preterm medicines. Numerous government bodies and NGOs are working towards reducing the premature birth by funding and promoting advantages of regular check-up during pregnancy. For instance, since 2004, the March of Dimes, a non-profit organization in the U.S., has been financing for research based on the causes of premature birth

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Pregabalin Market 2022-2026

  • $ 2500
  • September 2022
  • 120 pages

Global Pregabalin Market 2022-2026 The analyst has been monitoring the pregabalin market and it is poised to grow by $153.03 mn during 2022-2026, accelerating at a CAGR of 3.74% during the forecast period. ...

  • World
  • Healthcare
  • Pharmaceutical
  • Industry analysis
  • Health Expenditure
  • Diabetes Incidence

VPN Software Market $ 5000 September 2022


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on